Ahmed Ahidouch
Overview
Explore the profile of Ahmed Ahidouch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bantsimba-Malanda C, Ahidouch A, Rodat-Despoix L, Ouadid-Ahidouch H
Cell Calcium
. 2023 May;
113:102760.
PMID: 37247443
Breast cancer (BC) is the second most common cancer and cause of death in women. The aggressive subtypes including triple negative types (TNBCs) show a resistance to chemotherapy, impaired immune...
2.
Schnipper J, Kouba S, Hague F, Girault A, Telliez M, Guenin S, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230869
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with a low overall survival rate of less than 10% and limited therapeutic options. Fluctuations in tumor microenvironment pH...
3.
Kouba S, Hague F, Ahidouch A, Ouadid-Ahidouch H
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142596
In the fight against cancer, therapeutic strategies using cisplatin are severely limited by the appearance of a resistant phenotype. While cisplatin is usually efficient at the beginning of the treatment,...
4.
Schnipper J, Kouba S, Hague F, Girault A, Rybarczyk P, Telliez M, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887266
Dysregulation of the transient receptor canonical ion channel (TRPC1) has been found in several cancer types, yet the underlying molecular mechanisms through which TRPC1 impacts pancreatic ductal adenocarcinoma (PDAC) cell...
5.
Schnipper J, Dhennin-Duthille I, Ahidouch A, Ouadid-Ahidouch H
Front Pharmacol
. 2020 Nov;
11:568993.
PMID: 33178018
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer-related deaths in United States and Europe. It is predicted that PDAC will become the second leading cause of...
6.
Ouadid-Ahidouch H, Morjani H, Schnipper J, Girault A, Ahidouch A
Rev Physiol Biochem Pharmacol
. 2020 Aug;
181:1-38.
PMID: 32761457
In recent years, it has been shown that breast cancer consists not only of neoplastic cells, but also of significant alterations in the surrounding stroma or tumor microenvironment. These alterations...
7.
Girault A, Ahidouch A, Ouadid-Ahidouch H
Biochim Biophys Acta Mol Cell Res
. 2020 Jan;
1867(4):118644.
PMID: 31931022
For twenty years, ion channels have been studied in cancer progression. Several information have been collected about their involvement in cancer cellular processes like cell proliferation, motility and their participation...
8.
Gueder N, Allan G, Telliez M, Hague F, Fernandez J, Sanchez-Fernandez E, et al.
J Cell Physiol
. 2017 Feb;
232(12):3631-3640.
PMID: 28145580
Aberrant glycosylation changes on many glycoproteins are often related to cancer progression and metastasis. sp -Iminosugar-type castanospermine analogues, inhibitors of α-glucosidases, have been reported to exhibit antitumor activity. However, their...
9.
Benzerdjeb N, Sevestre H, Ahidouch A, Ouadid-Ahidouch H
Oncotarget
. 2016 Nov;
7(49):81588-81597.
PMID: 27835593
Orai3 channel has emerged as important player in malignant transformation. Indeed, its expression is increased in cancer and favors cell proliferation and survival by permitting calcium influx. In this study,...
10.
Faouzi M, Hague F, Geerts D, Ay A, Potier-Cartereau M, Ahidouch A, et al.
Oncotarget
. 2016 May;
7(24):36419-36435.
PMID: 27183905
Intracellular Ca2+ levels are important regulators of cell cycle and proliferation. We, and others, have previously reported the role of KCa3.1 (KCNN4) channels in regulating the membrane potential and the...